TB Alternative Assets’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

TB Alternative Assets’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,071,865	Closed	-$528K	–	45
2023 Q1	$528K	Hold	2,071,865	–	–	0.13%	36
2022 Q4	$2.44M	Hold	2,071,865	–	–	0.88%	28
2022 Q3	$4.23M	Hold	2,071,865	–	–	1.52%	17
2022 Q2	$3.19M	Hold	2,071,865	–	–	1.56%	19
2022 Q1	$10.5M	Hold	2,071,865	–	–	3.59%	6
2021 Q4	$12.8M	Buy	+2,071,865	New	+$18.5M	3.8%	5

TB Alternative Assets's PEAR Position: Q2 2023 in Review

TB Alternative Assets sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 2,071,865 shares — an estimated $528K sold.

TB Alternative Assets first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $12.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

TB Alternative Assets reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
TB Alternative Assets sold 2,071,865 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $528K.
TB Alternative Assets first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
TB Alternative Assets's Pear Therapeutics, Inc. Class A Common Stock position peaked at $12.8M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on TB Alternative Assets's 13F filing for Q2 2023, filed 21 Jul 2023.